'Today, I am satisfied': In a First, PM Modi talks about leading battle against Covid, rush to bring vaccine

-

New Delhi: It seemed like a war that India would never be able to tackle, let alone conquer. When the Covid-19 pandemic struck the world, many estimated that a country as large and diverse as India would be at the mercy of the virus that had brought several developed and wealthy nations to their knees.

But turning a deaf ear to fears of never-seen-before destruction, one man had begun charting out the course for his country to not only fight the Covid-19 pandemic but also emerge victorious.

Sharing his experience of battling an invisible enemy in History TV18’s brand new documentary ‘The Vial – India’s Vaccine Story’, Prime Minister Narendra Modi said till people were educated, brought together and given the onus of saving themselves and their families from the virus, results could never be seen.

“Our available health infrastructure was for a normal situation. But in a situation where the whole country is battling a pandemic, the resources would fall short. Considering this, to bridge the gap between demand and supply, we decided that however much money and budget is required, it should be pumped in,” the Prime Minister said.

Explaining the two options India had as the virus caught the world in a chokehold, PM Modi said: “We thought that should we wait for some country to develop the vaccine or should we analyse our genomic situation and develop a vaccine, keeping in mind the Indian population. We made a task force of scientists and decided that we will develop our vaccine, whatever may be the cost.”

PM Modi said the decision also meant inspiring confidence among industrialists to come forward and join the battle against the virus with help from the government.

The Prime Minister’s vision was shared by Union Health Minister Mansukh Mandaviya who said, “The government gave Rs 900 crore for research without any rider that only positive results would be encouraged or entertained. We just wanted them to be confident and continue the research.”

In the 60-minute documentary, aired at 8 pm on Friday (24 March), PM Modi also said the need of the hour was to develop a vaccine and for that, decision-making “could not move at the speed of files”. “We needed speed. It was important to adopt the ‘all of the government’ approach. At any given point of time, the government was talking to all stakeholders.”

The Prime Minister added that within a few days, “it was clear that we would have to work on a big canvas, on a big scale. Once we had clarity, we empowered people and began delegating power so people could take decisions.”

However, the challenge for India was not just to develop the vaccine — which it did — but also ensure it reaches a huge population in the prescribed time limit in the remotest corners of the country. “Even the wealthy nations could not manage more than 50-60 per cent inoculation. We didn’t want to take any risk so we depended on technology, trained grassroots-level people, and ensured basics such as the correct temperature for the vaccine,” he said, hailing the CoWIN App’s role in India’s smooth vaccination drive.

Summing up his battle against Covid-19, PM Modi said: “When the pages of history are turned and situations are analysed, India’s fight against coronavirus during this duration will be known as the time period of the highest service to mankind. Today, I am satisfied that the doctors, hospitals and scientists of my country did a remarkable job because of which there was no negativity around the vaccine which would shake India’s faith in the jab.”

‘The Vial – India’s Vaccine Story’ has many firsts and several untold stories. It also features interviews of vaccine manufacturers — Adar Poonawala, CEO of Serum Institute of India, and Dr Krishna Ella, chairman of Bharat Biotech — among others apart from detailing India’s initiatives such as the CoWIN App and Vaccine Maitri to help other countries with the vaccine.

Read all the Latest News, Trending News, Cricket News, Bollywood News,
India News and Entertainment News here. Follow us on Facebook, Twitter and Instagram.



from Firstpost India Latest News https://ift.tt/yva3ufE
FP Staff

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

120 flights delayed, 30 trains running late; Delhi fog & cold wave continue to give shiver to travellers

-
Arrival and departure of 120 flights, both domestic and international, to Delhi airport were affected due to dense fog and cold wave conditions on Wednesday, according to Delhi Airport FIDS (Flight Information Display System). As per the Delhi Airport FIDS, a total of 53 flights, including 21 domestic arrivals, 16 domestic departures, 13 international departures and three international arrivals scheduled are cancelled and not operating due to fog and other operational reasons from and to Indira Gandhi International (IGI) Airport in the national capital on 17 January. #WATCH | Delhi: Several flight operations delayed at IGI airport due to low visibility amid fog. pic.twitter.com/hG1DUKllEt — ANI (@ANI) January 17, 2024 Visuals from the Delhi airport showed passengers waiting outside, checking update of their scheduled flights. There were also some people waiting for flight of their families, friends and loved ones to arrive, which got delayed due to fog. #WATCH | Delhi | Pas
Read more